This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Innovation in medical technology exists to improve patient outcomes, increase surgical efficiency and enhance patient safety. Infrequently, we see medical technologyinnovation of a paradigmatic nature that changes the way physicians approach disease states and dramatically improve results.
The Heart Rhythm Society (HRS) is preparing for HRX 2024, the third annual event of its kind, which will be held from September 5-7, 2024, in Atlanta, GA, gathering cardiovascular health innovators together to explore discoveries and advance partnerships between medicine and technology.
DALLAS, June 13, 2024 — The American Heart Association, through its Center for Health Technology and Innovation (the Center), has selected five companies to participate in the American Heart Association Heart and Brain Health Accelerator.
milla1cf Mon, 05/13/2024 - 11:08 May 13, 2024 — Innovative Health , Inc.announced that recent growth in single-use device reprocessing has delivered significant financial and environmental benefits to U.S. HRS attendees can visit Innovative Health at booth No. electrophysiology labs.
mtaschetta-millane Thu, 07/25/2024 - 08:55 July 25, 2024 — Nanox, an innovative medical imaging technology company, announced that the AI Cardiac Solution (HealthCCSng) of its subsidiary, Nanox.AI We would also like to thank SCCT for the opportunity to showcase the outstanding clinical results of our AI cardiac solution.”
Insights into technology and what the future holds for MRI, CT and more were among our most viewed articles by far. We’ll continue to bring you these insights and many more in 2024. As we reviewed our most popular publications of 2023, it became clear that many of you continue to rethink the limits of your profession.
RCE Technologies, Inc. RCE) is an innovative artificial intelligence (AI) based medical technology company dedicated to early heart attack detection. milla1cf Mon, 04/22/2024 - 15:05 April 22, 2024 — At the annual American College of Cardiology conference ( ACC.24 Featured in an ACC.24 Featured in an ACC.24
milla1cf Mon, 06/17/2024 - 20:34 June 17, 2024 — aycan , a recognized leader in medical imaging, announced today a reseller and technology partnership with AI4MedImaging, a company that specializes in applying artificial intelligence ( AI ) to medical imaging. and Germany.
milla1cf Wed, 02/07/2024 - 18:05 February 7, 2024 — The Consumer Technology Association ( CTA ) and the American College of Cardiology ( ACC ) are announcing the release of their second industry framework for the use of consumer cardiovascular technology solutions in the screening and diagnosis for cardiovascular conditions.
milla1cf Thu, 05/30/2024 - 10:31 May 30, 2024 — Stereotaxis , a pioneer in surgical robotics for minimally invasive endovascular intervention, announced the successful treatment of the first heart rhythm patients by Penn Presbyterian Medical Center (PPMC) utilizing the advanced Genesis Robotic Magnetic Navigation System.
Getty Images milla1cf Mon, 04/01/2024 - 08:21 April 1, 2024 — Roughly 25,000 Americans die each year from valvular heart disease, but researchers from Rutgers Health and other institutions conclude that new technology could soon help doctors slash that number. “We What is Valvular Heart Disease?
Pocket-Sized Kardia 12L ECG System milla1cf Tue, 06/25/2024 - 18:55 June 25, 2024 — AliveCor , the global leader in AI -powered cardiology, today announced the U.S. Food and Drug Administration ( FDA ) clearance and commercial launch of KAI 12L AI technology and the Kardia 12L ECG System.
Getty Images milla1cf Wed, 03/06/2024 - 18:45 March 6, 2024 — Ensight-AI , a Yale start-up and leader in AI -based cardiovascular diagnostics, announces the receipt of the U.S. Food and Drug Administration’s ( FDA ) Breakthrough Device Designation for their ECGvision-TTR Technology for early detection of ATTR-Cardiomyopathy.
milla1cf Mon, 03/18/2024 - 07:30 March 18, 2024 — SS Innovations International, Inc. , Dr. Srivastava said: “SS Innovations is dedicated to improving patient access and optimizing surgical outcomes with our accessible and cost-effective surgical robotic system. The mitral valve disease market size was valued at $2.5
We look forward to bringing our AI technology to meet patients and physicians where they are, ultimately benefiting both worldwide.” The companies will also work together to validate the clinical utility of the integrated solution and seek regulatory clearance to bring this technology to market. Under the agreement, InfoBionic.Ai
The American Heart Association, commemorating its 100th year, has announced its volunteer leadership for fiscal year 2024-2025, which includes Keith Churchwell, MD, FAHA, a cardiologist renowned as a health equity champion, and Marsha Jones, an executive leader in workplace diversity and inclusion. Keith Churchwell, M.D., in Pittsburgh.
June 4, 2024 — The countdown has begun ahead of the American Society of Echocardiography 35th Annual ASE Scientific Sessions, June 14-26, at the Oregon Convention Center in Portland, OR. The Program Chair for ASE 2024 is Federico Asch, MD, FASE, MedStar Health and Georgetown University (Wash.,
Luigi Caliendo explains the benefits of Robotic Technology to President Vincenzo de Luca. Luigi Caliendo explains the benefits of Robotic Technology to President Vincenzo de Luca. We are proud to lead the way in Italy, revolutionizing cardiac treatment through innovative robotic technology."
tim.hodson Wed, 10/16/2024 - 14:46 Oct. 11, 2024 – As the pace of change accelerates in healthcare, the most pressing questions in cardiovascular medicine demand immediate answers. These challenges and more will be tackled head-on at the third annual TCT MedTech Innovation Forum on Oct. 27, at the Walter E.
milla1cf Wed, 01/03/2024 - 12:09 January 3, 2024 — iRhythm Technologies, Inc. , With improved clinical accuracy compared to existing traditional Holter monitoring 6,7 , we look forward to introducing our innovativetechnology to many more patients in Europe.” iRhythm Technologies, 2022. Data on file.
Image courtesy: Philips christine.book Wed, 06/12/2024 - 14:07 June 12, 2024 — Royal Philips has announced its next-generation AI-enabled cardiovascular ultrasound platform to help speed up cardiac ultrasound analysis with proven AI technology and reduce the burden on echocardiography labs.
milla1cf Wed, 04/24/2024 - 19:03 April 24, 2024 — Expanse ICE announced today the ICE Aspiration System has received 510(k) clearance from the U.S. It is cutting-edge technology in an underpenetrated market," said Shlomi Nachman , former Johnson & Johnson Company Group Chairman of Cardiovascular & Specialty Solutions and Vision.
mtaschetta-millane Thu, 06/20/2024 - 08:32 June 19, 2024 — Royal Philips , a global leader in health technology, today announced the launch of Philips Image Guided Therapy Mobile C-arm System 9000 – Zenition 90 Motorized , designed to help clinicians deliver high-quality care to more patients.
milla1cf Fri, 02/02/2024 - 17:18 February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 with CardioLab EP Recording system, to help clinicians in the diagnosis and treatment of cardiac arrhythmias. million people in the United States by 2050 and 17.9
milla1cf Thu, 03/07/2024 - 20:10 March 7, 2024 — GE HealthCare will showcase its industry-leading portfolio of artificial intelligence ( AI )-enabled medical devices and digital solutions in Booth 2500 at the Health Information and Management Systems Society ( HIMSS ) Global Health Conference and Exhibition in Orlando, FL from March 11-15, 2024.
mtaschetta-millane Tue, 07/16/2024 - 09:47 July 16, 2024 — Ultrahuman, a pioneer in wearable technology , launches PowerPlugs, a platform for individual apps and plugins built on top of Ultrahuman’s health and wellness data stack. UltraSignal will help fuel more customization and innovation in health.
tim.hodson Fri, 11/08/2024 - 13:23 Nov. 4, 2024 — Royal Philips recently announced enrollment of the first patient in the U.S. THOR IDE clinical trial, which will study an innovative combined laser atherectomy and intravascular lithotripsy catheter that integrates two critical PAD treatments into a single device.
Innovative Health, Inc. electrophysiology labs, and will be participating in the Heart Rhythm Society annual meeting, HRS 2024, May 16-19 in Boston, MA. milla1cf Mon, 05/13/2024 - 11:08 May 13, 2024 — Innovative Health , Inc. electrophysiology labs. The company recently received its 47th clearance from FDA.
Positron joins forces with the coalitions founding members, Bracco Diagnostics , CDL Nuclear Technologies and Siemens Healthcare who have come together to promote federal policies that advance health outcomes for patients with cardiovascular disease and improve the availability of cardiac PET diagnostics throughout the United States.
Medical device company Visura Technologies, Inc. has announced the TEECADE mini, an initiative for the next innovation in transesophageal echocardiography (TEE) imaging technology. Image courtesy: Visura Technologies, Inc. christine.book Thu, 06/13/2024 - 13:09 June 13, 2024 — Visura Technologies, Inc. ,
Getty Images milla1cf Wed, 06/05/2024 - 20:33 June 5, 2024 — Edwards Lifesciences announced it has entered into a definitive agreement to sell its Critical Care product group to BD (Becton, Dickinson and Company), in an all-cash transaction valued at $4.2 Other terms of the agreement were not disclosed.
2024 was a year of innovation across the imaging spectrum. When we reviewed our top articles of the year, it became clear that what resonated more than anything else were in-depth looks at technology, the cost of that technology, and the myriad other innovations changing the clinical conversation.
mtaschetta-millane Mon, 07/29/2024 - 09:02 July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing patient care through structural heart innovation, addressing large unmet patient needs and supporting sustainable long-term growth.
tim.hodson Tue, 06/11/2024 - 17:21 On July 16, Diagnostic and Interventional Cardiology will present a webinar on "Maximizing Structural Heart Workflows: Harnessing the Power of CVIS and AI." Additionally, Schalit–Cohen will delve into the realm of AI technologies and their potential to support structural heart workflows.
Getty Images milla1cf Fri, 04/12/2024 - 20:55 April 12, 2024 — Simpson Interventions, Inc. , This designation recognizes the transformative potential of our technology in addressing a critical unmet need in the treatment of patients with coronary chronic total occlusions. Food and Drug Administration ( FDA ).
tim.hodson Thu, 12/05/2024 - 11:59 Dec. 4, 2024 – Cleerly has successfully closed its latest Series C extension funding round, raising a total of $106 million. As we’ve seen with their recent Medicare and CPT I code approvals, this technology is both valuable and ready today in the fight against heart disease.”
milla1cf Mon, 05/06/2024 - 10:55 May 6, 2024 — SMT (Sahajanand Medical Technologies), a leading medical device company at the forefront of innovative patient care in the cardiovascular segment has announced a strategic partnership with HeartX , a pioneering MedTech company focused on research and development.
The collaboration seeks to provide access to emerging technologies, like Medis QFR, while also reducing complexity in the cath lab to improve the operating environment for clinicians. Medis Medical Imaging has been developing innovative post-processing software for the quantification of cardiovascular images for thirty-five years.
An international consensus statement on how to treat atrial fibrillation with catheter or surgical ablation has been published in EP Europace, a journal of the European Society of Cardiology (ESC), and was recently presented at EHRA 2024, a scientific congress held April 7-9 in Berlin, Germany. Image courtesy: European Society of Cardiology.
Getty Images mtaschetta-millane Mon, 07/15/2024 - 11:06 July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd. , We believe the Innovalve technologies, paired with Edwards’ deep mitral expertise, will enable a TMVR platform that will expand the treatable population.”
v As cardiovascular disease (CVD) continues to rise globally, vi the need for advanced diagnostic technologies like cardiac CT angiography (CCTA) becomes increasingly critical. vii Similarly, recent increases in Medicare reimbursement rates for CCTA are a positive step towards making this technology more accessible.
Mike Black milla1cf Wed, 04/17/2024 - 16:15 April 17, 2024 — CPR Therapeutics, Inc. to develop the next generation technology for cardiopulmonary resuscitation, announced today that Mike Black will be advising the Company as its first Chief Strategy Officer. ACSI), one of the few start-ups to innovate significantly in CPR.
Image courtesy: Circle Cardiovascular christine.book Thu, 07/18/2024 - 13:32 July 18, 2024 — Circle Cardiovascular Imaging , a developer of artificial intelligence (AI)-driven cardiovascular imaging solutions, has announced that Erkan Akyuz has been appointed Chief Executive Officer, effective August 5, 2024.
In 2024, the FDA approved Flyrcado for patients with known or suspected coronary artery disease (CAD), delivering higher diagnostic efficacy compared to single-photon emission computed tomography (SPECT) i myocardial perfusion imaging (MPI), the predominant procedure used in nuclear cardiology today. Dorbala, S., Di Carli,M. Bateman, T.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content